A Case of Multiple Myeloma in a 17-Year-Old Girl Treated with Autologous Hematopoietic Stem Cell Transplantation (ASCT)

Am J Case Rep. 2019 Nov 5:20:1623-1629. doi: 10.12659/AJCR.917670.

Abstract

BACKGROUND Multiple myeloma is mainly a disease of the elderly. The diagnosis of multiple myeloma in patients under 30 years of age is rare. A rare case is presented of a 17-year-old girl diagnosed with multiple myeloma who was successfully treated with autologous hematopoietic stem cell transplantation (ASCT). CASE REPORT A 17-year-old Vietnamese girl presented with pain in the left hip and difficulty walking. She was diagnosed with stage IIIA IgG lambda (l) multiple myeloma and was treated with a bortezomib-based chemotherapy regimen followed by ASCT. The patient showed a good response to treatment. At 14-month follow-up, her bone pain had resolved, and her ability to walk was improved. CONCLUSIONS A rare case of multiple myeloma is presented in a 17-year-old girl who responded well to ASCT.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Bortezomib / therapeutic use*
  • Combined Modality Therapy
  • Dexamethasone / therapeutic use*
  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Multiple Myeloma / diagnosis*
  • Multiple Myeloma / therapy*
  • Neoplasm Staging
  • Transplantation, Autologous
  • Treatment Outcome

Substances

  • Bortezomib
  • Dexamethasone